Neurocognitive prediction of illness knowledge after psychoeducation in schizophrenia: results from the Munich COGPIP study

Abstract

Neurocognition, not psychopathology, is a significant predictor of illness knowledge after psychoeducation in schizophrenia. This finding should guide efforts to tailor psychoeducational interventions more closely to the patient's needs and resources.

References

Page 1

	Year	Citations
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia Stanley R. Kay, Abraham Fiszbein, Lewis A. Opler Schizophrenia Bulletin PsychopathologyPsychiatryPsychotic DisorderDepressionSchizophrenia	1987	21K
Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Neil S. Jacobson, Paula Truax Journal of Consulting and Clinical Psychology PsychotherapyTreatment EffectMental HealthPsychologySocial Sciences	1991	8K
A Modified Card Sorting Test Sensitive to Frontal Lobe Defects Hazel E. Nelson Cortex NeuropsychologyBrain FunctionMedicineNeuroimagingFrontal Lobe Defects	1976	2.5K
The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity Keith H. Nuechterlein, Michael F. Green, Robert S. Kern, American Journal of Psychiatry	2008	2.3K
Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association American Journal of Psychiatry NursingPractice GuidelinePsychiatric EvaluationPsychiatryAmerican Psychiatric Association	1997	1.4K
What does the PANSS mean? S. Leucht, Jamie Kane, W. Kissling, Schizophrenia Research HumanitiesSocial CriticismDiscourse AnalysisCritical TheoryLanguage Studies	2005	1.2K
The MATRICS Consensus Cognitive Battery, Part 2: Co-Norming and Standardization Robert S. Kern, Keith H. Nuechterlein, Michael F. Green, American Journal of Psychiatry	2008	732
LibGuides: Assessment Tools: Revised comprehensive norms for an expanded Halstead-Reitan battery demographically adjusted neuropsychological norms for African American and Caucasian adults Hal Loewen Neuropsychological FunctioningNeuropsychologyPsychiatryCross-cultural AssessmentPsychology	2011	655
The Clinical Global Impression–Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia Josep María Haro, Shanta Kamath, Susana Ochoa, Acta Psychiatrica Scandinavica	2003	643
Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial Richard S.E. Keefe, Robert M. Bilder, Philip D. Harvey, Neuropsychopharmacology Catie Schizophrenia TrialNeuropsychological FunctioningNeuropsychologyPsychiatryPsychotic Disorder	2006	467

Page 1